These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38134256)

  • 1.
    Prescott DF; Quinn TJ
    Stroke; 2024 Jan; 55(1):e10-e11. PubMed ID: 38134256
    [No Abstract]   [Full Text] [Related]  

  • 2. Pragmatic trial of multifaceted intervention (STROKE-CARD care) to reduce cardiovascular risk and improve quality-of-life after ischaemic stroke and transient ischaemic attack -study protocol.
    Toell T; Boehme C; Mayer L; Krebs S; Lang C; Willeit K; Prantl B; Knoflach M; Rumpold G; Schoenherr G; Griesmacher A; Willeit P; Ferrari J; Lang W; Kiechl S; Willeit J
    BMC Neurol; 2018 Nov; 18(1):187. PubMed ID: 30400876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Secondary prevention of cardiovascular and cerebrovascular complications after ischemic stroke].
    Ostroumova OD; Bondarets OV
    Kardiologiia; 2014; 54(5):80-7. PubMed ID: 25177893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotics for secondary prevention of coronary heart disease.
    Sethi NJ; Safi S; Korang SK; Hróbjartsson A; Skoog M; Gluud C; Jakobsen JC
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD003610. PubMed ID: 33704780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the Cochrane Review: Fibrates for secondary prevention of cardiovascular disease and stroke.
    Pires da Rosa G; Libânio D; Filipe Azevedo L
    Rev Port Cardiol; 2017 Jan; 36(1):55-58. PubMed ID: 27979321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of cardiovascular disease and stroke: meeting the challenge.
    Tomaselli GF
    JAMA; 2011 Nov; 306(19):2147-8. PubMed ID: 22089723
    [No Abstract]   [Full Text] [Related]  

  • 7. Lifestyle Interventions to Prevent Cardiovascular Events After Stroke and Transient Ischemic Attack: Systematic Review and Meta-Analysis.
    Deijle IA; Van Schaik SM; Van Wegen EE; Weinstein HC; Kwakkel G; Van den Berg-Vos RM
    Stroke; 2017 Jan; 48(1):174-179. PubMed ID: 27924055
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Gartly R; Quinn TJ
    Stroke; 2023 Nov; 54(11):e483-e484. PubMed ID: 37871242
    [No Abstract]   [Full Text] [Related]  

  • 9. Small but Steady Steps in Stroke Medicine in Japan.
    Toyoda K; Inoue M; Koga M
    J Am Heart Assoc; 2019 Aug; 8(16):e013306. PubMed ID: 31390925
    [No Abstract]   [Full Text] [Related]  

  • 10. Treating Dyslipidemia for the Primary and Secondary Prevention of Stroke.
    Barkas F; Milionis H
    Semin Neurol; 2017 Jun; 37(3):286-293. PubMed ID: 28759910
    [No Abstract]   [Full Text] [Related]  

  • 11. Practice variation in long-term secondary stroke prevention in The Netherlands.
    van Schaik SM; de Vries BS; Weinstein HC; Visser MC; Van den Berg-Vos RM
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):566-72. PubMed ID: 25543189
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Mani KK; Sohrabji F
    Stroke; 2024 Apr; 55(4):e119-e120. PubMed ID: 38527141
    [No Abstract]   [Full Text] [Related]  

  • 13. Our Efforts for Ideal Stroke Prevention and Treatment in Japan.
    Yamaguchi T
    Stroke; 2022 Mar; 53(3):1030-1036. PubMed ID: 35012327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The participation of Arab women in randomised clinical trials for cardiovascular diseases.
    Al Sharie S; Araydah M; Al-Azzam S; Karasneh R; Hammoudeh AJ
    Int J Clin Pract; 2021 Nov; 75(11):e14612. PubMed ID: 34235821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics.
    Nidorf SM; Fiolet ATL; Eikelboom JW; Schut A; Opstal TSJ; Bax WA; Budgeon CA; Tijssen JGP; Mosterd A; Cornel JH; Thompson PL;
    Am Heart J; 2019 Dec; 218():46-56. PubMed ID: 31706144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypill strategy at the heart of cardiovascular secondary prevention.
    Ibañez B; Castellano JM; Fuster V
    Heart; 2019 Jan; 105(1):9-10. PubMed ID: 30030331
    [No Abstract]   [Full Text] [Related]  

  • 17. Canadian Stroke Best Practice Recommendations, seventh edition: acetylsalicylic acid for prevention of vascular events.
    Wein T; Lindsay MP; Gladstone DJ; Poppe A; Bell A; Casaubon LK; Foley N; Coutts SB; Cox J; Douketis J; Field T; Gioia L; Habert J; Lang E; Mehta SR; Papoushek C; Semchuk W; Sharma M; Udell JA; Lawrence S; Mountain A; Gubitz G; Dowlatshahi D; Simard A; de Jong A; Smith EE;
    CMAJ; 2020 Mar; 192(12):E302-E311. PubMed ID: 32392513
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrates for secondary prevention of cardiovascular disease and stroke.
    Wang D; Liu B; Tao W; Hao Z; Liu M
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD009580. PubMed ID: 26497361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of stroke prevention trials: treatment of global risk.
    Elkind MS
    Neurology; 2005 Jul; 65(1):17-21. PubMed ID: 16009880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density lipoprotein cholesterol lowering for the prevention of cardiovascular outcomes in patients with ischemic stroke.
    Ntaios G; Milionis H
    Int J Stroke; 2019 Jul; 14(5):476-482. PubMed ID: 31092149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.